Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
about
Surgical and molecular pathology of pancreatic neoplasmsClinicopathological Significance of CDKN2A Promoter Hypermethylation Frequency with Pancreatic CancerHuman β-cell proliferation and intracellular signaling: part 3Summary of emerging personalized medicine in neuroendocrine tumors: are we on track?Menin determines K-RAS proliferative outputs in endocrine cellsIslet biology, the CDKN2A/B locus and type 2 diabetes risk.Inflammatory mechanisms contributing to pancreatic cancer development.Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors.Nuclear receptors and pathogenesis of pancreatic cancer.Precursor lesions for sporadic pancreatic cancer: PanIN, IPMN, and MCN.DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagusO6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: prognostic relevance and association with response to alkylating agentsResolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.Advances in biomarker research for pancreatic cancer.Molecular pathology of pancreatic neuroendocrine tumors.Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor CellsEpigenetic changes in gliomas.Deletion of retinoic acid receptor β (RARβ) impairs pancreatic endocrine differentiation.Molecular pathogenesis of pancreatic neuroendocrine tumors.NETs: organ-related epigenetic derangements and potential clinical applications.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Clinical and Preclinical Advances in Gastroenteropancreatic Neuroendocrine Tumor Therapy.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.
P2860
Q26748615-FB4A6495-B038-4BA0-9825-F968CFBA1F09Q26785691-B84A28AF-4E9D-4C8A-A660-E36521FC03E1Q26821954-B0CD6295-687C-4C6D-9DB7-697E6E3937D5Q28078610-64D94183-C1F6-4E34-921B-D0717811D4B3Q28589291-28EA5F10-AA64-4EAE-9662-973969751510Q30251397-7D037D82-4A5E-47A0-9578-88E717C3CF9FQ31067795-91E7D898-1493-435D-894F-32A8310C9A1FQ33991964-56753FAF-D817-409C-9C15-D954E66D5CD2Q34168476-4E2E4AD5-674D-429A-A415-76E3EE96868DQ34661643-552A160F-A791-441C-BE19-0AD9506776C3Q34958192-2D716D8C-3D77-42DA-A222-F2F2F20CD1B7Q35677887-B1DF717B-3BF9-4191-8004-52AB3A129F3FQ35922060-ADA772D1-6CDE-40FE-AEE1-08C0BC8D1052Q36126609-E5F69F17-5F4F-4BA5-AE0E-054EC4909AB6Q36162528-5F85F836-731A-406E-B9A3-0991829F8A2AQ37175960-5E5E353E-AA40-4F72-AC7E-3CAF331E420DQ37280291-BE2BFD76-DF62-45EC-863E-97542CED2D7EQ37287032-41F2238B-BFE7-4DE3-A228-880F5982694EQ37290650-E59B2070-0113-4F9F-B538-C08AF0BBB951Q38166586-61D9AC47-863D-415B-824D-ED2D1A0E7623Q38841735-7DEC3D21-592E-4FEB-87DC-7D04EEA8C3FDQ42115029-FF70143F-641E-430E-847C-29ED396DF5B0Q47128709-1AB49D0E-872C-428B-9BBE-1AC2A0D0E4B9Q48295398-FC2BA45A-7335-47D9-9CCA-84249524E01C
P2860
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@en
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@nl
type
label
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@en
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@nl
prefLabel
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@en
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@nl
P2093
P2860
P1433
P1476
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
@en
P2093
Anirban Maitra
Charles J Yeo
Craig M Hooker
James G Herman
John L Cameron
Keith D Lillemoe
Michael G House
Ming Zhou Guo
Richard D Schulick
P2860
P304
423-31; discussion 431-2
P356
10.1097/01.SLA.0000086659.49569.9E
P407
P577
2003-09-01T00:00:00Z